-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on BioXcel Therapeutics (BTAI)
-
-
-
-
-
-
-
BioXcel Therapeutics (BTAI) PT Lowered to $10 at H.C. Wainwright
-
-
-
-
-
-
-
BioXcel Therapeutics (BTAI) PT Raised to 'Street High' $200 at H.C. Wainwright
-
-
-
-
-
-
-
BioXcel Therapeutics Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

